HEALTHSTREAM INC (HSTM)

29.38 +1.91% (+0.55)

Over 5Y: +1.3%

2026-08-28
20 25 30 35
2021 2022 2023 2024 2025 2026

Financials Quarterly

Q3 '25 — Revenue: 76.5M Q3 '25 — Operating Cash Flow: 18M Q3 '25 — Free Cash Flow: 17.9M Q3 '25 — Net Income: 6.1M Q4 '25 — Revenue: 79.7M Q4 '25 — Operating Cash Flow: 13.2M Q4 '25 — Free Cash Flow: 13M Q4 '25 — Net Income: 2.5M Q1 '26 — Revenue: 81.2M Q1 '26 — Operating Cash Flow: 27.1M Q1 '26 — Free Cash Flow: 26.4M Q1 '26 — Net Income: 5.9M Q2 '26 — Revenue: 83.7M Q2 '26 — Operating Cash Flow: 13.4M Q2 '26 — Free Cash Flow: 12.5M Q2 '26 — Net Income: 6.7M 0 20M 40M 60M 80M 100M
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

4.4
OE margin 19.1%
ROIC 7.0%
Accruals -9.7%
OCF / EBIT 2.8×
FCF margin 21.7%
Gross margin 51.2%
OCF margin 22.4%
ROA 4.1%
ROCE 6.5%
ROE 5.9%

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

8.7
RPO / sales 2.1×
RPO growth 10.8%
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

9.7
Interest cover 255.5×
ND/EBITDA —
Debt / Eq 0.0×
Debt payback 0.0 yr
Payout 18.4%
Quick ratio 1.1×
F-score 5.6 pts
Cash / Debt —
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

3.8
Sales/sh Y/Y +10.2%
EPS CAGR 4Y +35.7%
Div. growth +9.6%
EBIT CAGR +23.2%
EBIT Y/Y +20.3%
EPS Y/Y +5.6%
Sales Q/Q +12.5%
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.